Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
2022 · npj Precision Oncology · 48 citations
https://doi.org/10.1038/s41698-021-00245-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
590
Citations
12
h-index
13
i10-index
Daniel F. Comiskey is an academic researcher from The Ohio State University. The author has contributed to research in topics: RNA Research and Splicing & RNA modifications and cancer & Cancer-related Molecular Pathways. The author has an h-index of 12, co-authored 31 publications.
ORCID: 0000-0002-7269-4238https://doi.org/10.1038/s41698-021-00245-5
https://doi.org/10.1593/neo.13286
https://doi.org/10.1002/ijc.33488
Click to start Chat